Neo-Adjuvant Study in Triple Negative Breast Cancer Patients (ICE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01097642
Recruitment Status : Active, not recruiting
First Posted : April 1, 2010
Last Update Posted : September 14, 2016
Bristol-Myers Squibb
The Methodist Hospital System
Information provided by (Responsible Party):
Jenny C. Chang, MD, The Methodist Hospital System

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2016